Trial Profile
Attributes of Response in Depressed Patients Switched to Treatment With Duloxetine (ARDENT Study).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms ARDENT
- Sponsors Eli Lilly and Company
- 01 Sep 2009 Actual patient number (242) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.